VCAM1 and type 2 diabetes mellitus: There were no significant differences in VCAM-1 levels at admission between T2D and ND patients (2935 ± 2253 ng/mL in the T2D group vs. 2758 ± 1265 ng/mL in the ND group, p = 0.73).